These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19004283)

  • 21. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.
    Philipovskiy AV; Smiley ST
    Infect Immun; 2007 Feb; 75(2):878-85. PubMed ID: 17118978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Yersinia pestis and the plague.
    Rollins SE; Rollins SM; Ryan ET
    Am J Clin Pathol; 2003 Jun; 119 Suppl():S78-85. PubMed ID: 12951845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of Type I Interferon through a Noncanonical Toll-Like Receptor 7 Pathway during Yersinia pestis Infection.
    Dhariwala MO; Olson RM; Anderson DM
    Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28847850
    [No Abstract]   [Full Text] [Related]  

  • 25. Growth of a pYV-bearing Yersinia pestis KIM5 in retail raw ground pork.
    Bhaduri S; Phillips JG
    Foodborne Pathog Dis; 2013 May; 10(5):467-71. PubMed ID: 23627929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Deadly Path: Bacterial Spread During Bubonic Plague.
    Gonzalez RJ; Miller VL
    Trends Microbiol; 2016 Apr; 24(4):239-241. PubMed ID: 26875618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague.
    Lemaître N; Sebbane F; Long D; Hinnebusch BJ
    Infect Immun; 2006 Sep; 74(9):5126-31. PubMed ID: 16926404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of Yersinia pestis in soil under natural conditions.
    Eisen RJ; Petersen JM; Higgins CL; Wong D; Levy CE; Mead PS; Schriefer ME; Griffith KS; Gage KL; Beard CB
    Emerg Infect Dis; 2008 Jun; 14(6):941-3. PubMed ID: 18507908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the infectiousness to mice of soil contaminated with Yersinia pestis-infected blood.
    Boegler KA; Graham CB; Montenieri JA; MacMillan K; Holmes JL; Petersen JM; Gage KL; Eisen RJ
    Vector Borne Zoonotic Dis; 2012 Nov; 12(11):948-52. PubMed ID: 22925020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Live-attenuated Yersinia pestis vaccines.
    Wang X; Zhang X; Zhou D; Yang R
    Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestis.
    Reithmeier-Rost D; Hill J; Elvin SJ; Williamson D; Dittmann S; Schmid A; Wilharm G; Sing A
    Microbes Infect; 2007 Jul; 9(8):997-1002. PubMed ID: 17556003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival protein A is essential for virulence in Yersinia pestis.
    Southern SJ; Scott AE; Jenner DC; Ireland PM; Norville IH; Sarkar-Tyson M
    Microb Pathog; 2016 Mar; 92():50-53. PubMed ID: 26724738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quantitative characteristics of the survival phenomenon in experimental plague].
    Aparin GP; Vershinina TI
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Nov; (11):30-3. PubMed ID: 6362297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of immune response in Yersinia pestis infection.
    Amedei A; Niccolai E; Marino L; D'Elios MM
    J Infect Dev Ctries; 2011 Sep; 5(9):628-39. PubMed ID: 21918303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response.
    Montminy SW; Khan N; McGrath S; Walkowicz MJ; Sharp F; Conlon JE; Fukase K; Kusumoto S; Sweet C; Miyake K; Akira S; Cotter RJ; Goguen JD; Lien E
    Nat Immunol; 2006 Oct; 7(10):1066-73. PubMed ID: 16980981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague.
    Zvi A; Rotem S; Zauberman A; Elia U; Aftalion M; Bar-Haim E; Mamroud E; Cohen O
    Vaccine; 2017 Oct; 35(44):5995-6006. PubMed ID: 28606812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-mediated protection against pulmonary Yersinia pestis infection.
    Parent MA; Berggren KN; Kummer LW; Wilhelm LB; Szaba FM; Mullarky IK; Smiley ST
    Infect Immun; 2005 Nov; 73(11):7304-10. PubMed ID: 16239527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral vaccination against plague using Yersinia pseudotuberculosis.
    Demeure CE; Derbise A; Carniel E
    Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioluminescent tracking of colonization and clearance dynamics of plasmid-deficient Yersinia pestis strains in a mouse model of septicemic plague.
    Zhou J; Bi Y; Xu X; Qiu Y; Wang Q; Feng N; Cui Y; Yan Y; Zhou L; Tan Y; Yang H; Du Z; Han Y; Song Y; Zhang P; Zhou D; Cheng Y; Zhou Y; Yang R; Wang X
    Microbes Infect; 2014 Mar; 16(3):214-24. PubMed ID: 24333143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional profiling of a mice plague model: insights into interaction between Yersinia pestis and its host.
    Liu H; Wang H; Qiu J; Wang X; Guo Z; Qiu Y; Zhou D; Han Y; Du Z; Li C; Song Y; Yang R
    J Basic Microbiol; 2009 Feb; 49(1):92-9. PubMed ID: 18759226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.